dc.contributor.author
Evens, Ricarda
dc.contributor.author
Reiche, Simon
dc.contributor.author
Marek, Roman M.
dc.contributor.author
Moon, Daa Un
dc.contributor.author
Groß, Rosa Elisa
dc.contributor.author
Romanello, Amy
dc.contributor.author
Jalilzadeh Masah, Dario
dc.contributor.author
Scicchitano Böckheler, Matteo
dc.contributor.author
Gutwinski, Stefan
dc.contributor.author
Montag, Christiane
dc.contributor.author
Mick, Inge
dc.contributor.author
Majić, Tomislav
dc.date.accessioned
2022-02-22T08:37:37Z
dc.date.available
2022-02-22T08:37:37Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/34088
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-33806
dc.description.abstract
Introduction: The current corona virus disease (COVID-19) pandemic has caused a serious global health crisis that has affected large parts of the public and private life worldwide, including the use of psychoactive substances. In this study, we investigated the effect of the COVID-19 pandemic on the use of serotonergic psychedelics, i.e., the settings in which people use psychedelics, the motives of usage, and the subjective quality of psychedelic experiences.
Methods: The study was part of an international, cross-sectional, internet-based survey (N = 5,049) available in five languages (English, German, Spanish, Italian, and Korean) carried out during the early phase of the pandemic from April to August 2020. Participants were asked to retrospectively rate settings and motives of psychedelic substance use before the pandemic and in the last 4 weeks during the pandemic, as well as changes in psychedelic experiences.
Results: Of n = 1,375 participants that reported the use psychedelics in 2019 or 2020, n = 642 (46.6%) also took psychedelics during the pandemic. During the pandemic, participants used psychedelics significantly less often in settings that were outside their home. Top motives to use psychedelics were comparable before and during the pandemic, but participants consumed less out of curiosity, to celebrate, or because friends took it, and more out of boredom. An increase in positively connoted, often pro-social experiences was observed. Two thirds of participants who used psychedelics during the pandemic claimed that psychedelics had helped them to deal better with the corona pandemic at least slightly.
Discussion: Changes in setting and motives were mostly in line with restrictions caused by control measures to contain the spread of the virus. The unexpected increase in positively connoted experiences possibly reflects a favorable interaction of environmental macro- and individual micro-contexts during the pandemic (e.g., by reducing the use in more uncontrolled recreational settings or by encouraging a strong self-selection of substance users due to the expectation of "bad trips"). Increased pro-social feelings under psychedelics might reflect a desire for social interactions in times of social distancing and pandemic-related stress and anxiety.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
pandemic (COVID-19)
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
732028
dcterms.bibliographicCitation.doi
10.3389/fpsyt.2021.732028
dcterms.bibliographicCitation.journaltitle
Frontiers in Psychiatry
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
12
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34803757
dcterms.isPartOf.eissn
1664-0640